GSK Investigational Site
Deerfield Beach, Florida 33442
0 studies enrolling now · 17 studies all time
What they study most
Advanced Breast Cancer, Alzheimer's Disease, Bowel Dysfunction, Breast Cancer, Colonic Neoplasms, Constipation, Diabetes Mellitus, Type 2, Fallopian Tube Cancer, Lung Cancer, Non-Small Cell, Metastatic Breast Cancer, Neoplasms, Neoplasms, Colon
Studies at this site
- Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer — Recruiting now
- A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer — Running, not enrolling
- Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer — Completed
- Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Participants With Platinum Resistant Ovarian Cancer — Stopped early
- GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer — Stopped early
- Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers — Stopped early
- Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers — Stopped early
- Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease — Completed
- Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain — Completed
- Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease — Completed
- A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes — Completed
- Safety and Efficacy Study of Albiglutide in Type 2 Diabetes — Completed
- Safety and Efficacy of Albiglutide in Type 2 Diabetes — Completed
- Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes — Completed
- A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes — Completed
- Retapamulin Versus Placebo in Secondarily-Infected Traumatic Lesions (SITL) — Completed
- Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain — Completed